Literature DB >> 25435340

Short Communication: Viral Suppression Is Associated with Increased Likelihood of Colorectal Cancer Screening Among Persons Living with HIV/AIDS.

Greer A Burkholder1, Ashutosh R Tamhane, Lauren E Appell, James H Willig, Michael S Saag, James L Raper, Andrew O Westfall, Michael J Mugavero.   

Abstract

With improved survival and aging, more persons living with HIV/AIDS (PLWHA) are at risk for colorectal cancer (CRC). This retrospective longitudinal study evaluated patient characteristics associated with CRC screening in our HIV cohort. Patients were followed beginning at age 50 years during a study period from January 1, 2003 to December 31, 2010 (n=265). During a median follow-up time of 1.7 years, only 30% of patients underwent CRC screening. The majority of screened patients received endoscopic screening (colonoscopy, 86%; sigmoidoscopy, 8%); among these patients, results were available for 68/75, and adenomatous polyps were found in 13%. No cases of CRC were reported. Among unscreened patients, only 23% had an external primary care provider, indicating an HIV provider was the expected source for CRC screening referral in the majority. Patients with time-varying suppressed HIV viral load were more likely to receive screening (HRadjusted=1.74; 95% CI: 1.05-2.87), independent of CD4 count. Our findings suggest HIV providers are more likely to address non-HIV-related healthcare maintenance when HIV is controlled. In addition, a significant number of neoplastic lesions are likely being missed in PLWHA who have not been screened for CRC. Provision of evidence-based preventive care in addition to HIV care is required for the aging population of PLWHA.

Entities:  

Mesh:

Year:  2015        PMID: 25435340      PMCID: PMC4426328          DOI: 10.1089/AID.2014.0256

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  38 in total

1.  Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Judith A Aberg; Joel E Gallant; Jean Anderson; James M Oleske; Howard Libman; Judith S Currier; Valerie E Stone; Jonathan E Kaplan
Journal:  Clin Infect Dis       Date:  2004-08-11       Impact factor: 9.079

2.  Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Authors:  Frank J Palella; Rose K Baker; Anne C Moorman; Joan S Chmiel; Kathleen C Wood; John T Brooks; Scott D Holmberg
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

3.  Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention.

Authors:  Jean-Pierre Reinhold; Marianne Moon; Craig T Tenner; Michael A Poles; Edmund J Bini
Journal:  Am J Gastroenterol       Date:  2005-08       Impact factor: 10.864

4.  Use of flexible sigmoidoscopy to screen for colorectal cancer in HIV-infected patients 50 years of age and older.

Authors:  Edmund J Bini; James Park; Fritz Francois
Journal:  Arch Intern Med       Date:  2006 Aug 14-28

5.  Provision of general and HIV-specific health maintenance in middle aged and older patients in an urban HIV clinic.

Authors:  Anandi N Sheth; Richard D Moore; Kelly A Gebo
Journal:  AIDS Patient Care STDS       Date:  2006-05       Impact factor: 5.078

6.  Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002.

Authors:  Roger Bedimo; Ray Y Chen; Neil A Accortt; James L Raper; Carol Linn; Jeroan J Allison; John Dubay; Michael S Saag; Craig J Hoesley
Journal:  Clin Infect Dis       Date:  2004-10-11       Impact factor: 9.079

7.  Colorectal cancer in HIV-infected patients: a case control study.

Authors:  Nir Wasserberg; Joseph W Nunoo-Mensah; Claudia Gonzalez-Ruiz; Robert W Beart; Andreas M Kaiser
Journal:  Int J Colorectal Dis       Date:  2007-02-21       Impact factor: 2.571

8.  Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.

Authors:  Rita B Effros; Courtney V Fletcher; Kelly Gebo; Jeffrey B Halter; William R Hazzard; Frances McFarland Horne; Robin E Huebner; Edward N Janoff; Amy C Justice; Daniel Kuritzkes; Susan G Nayfield; Susan F Plaeger; Kenneth E Schmader; John R Ashworth; Christine Campanelli; Charles P Clayton; Beth Rada; Nancy F Woolard; Kevin P High
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

9.  Clinical inertia in the management of low-density lipoprotein abnormalities in an HIV clinic.

Authors:  James H Willig; David A Jackson; Andrew O Westfall; Jeroan Allison; Pei-Wen Chang; James Raper; Michael S Saag; Michael J Mugavero
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

10.  Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.

Authors:  Pragna Patel; Debra L Hanson; Patrick S Sullivan; Richard M Novak; Anne C Moorman; Tony C Tong; Scott D Holmberg; John T Brooks
Journal:  Ann Intern Med       Date:  2008-05-20       Impact factor: 25.391

View more
  3 in total

1.  Factors Associated with Prescription of Opioids and Co-prescription of Sedating Medications in Individuals with HIV.

Authors:  Jessica S Merlin; Ashutosh Tamhane; Joanna L Starrels; Stefan Kertesz; Michael Saag; Karen Cropsey
Journal:  AIDS Behav       Date:  2016-03

Review 2.  Risk of Colorectal Cancer and Associated Mortality in HIV: A Systematic Review and Meta-Analysis.

Authors:  Tyler J OʼNeill; Joseph D Nguemo; Anne-Marie Tynan; Ann N Burchell; Tony Antoniou
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-01       Impact factor: 3.731

3.  Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study.

Authors:  Yan Zhao; Zunyou Wu; Jennifer M McGoogan; Cynthia X Shi; Aihua Li; Zhihui Dou; Ye Ma; Qianqian Qin; Ron Brookmeyer; Roger Detels; Julio S G Montaner
Journal:  Clin Infect Dis       Date:  2018-02-10       Impact factor: 9.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.